AMSTERDAM, November 3 /PRNewswire/ --

- University of Miami First Academic Institution in the U.S. to use 
Scopus Custom Data for Research Measurement

Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, announced today its collaboration with the
University of Miami for use of Scopus(R) custom data (SCD) at the institution
to track and measure faculty research and scholarly activity.

Scopus, the largest abstract and citation database of peer-reviewed
literature, was chosen by the University of Miami because the breadth of the
content allows the university to accurately capture the greatest amount of
faculty research activity from a single data source. This also makes Miami
the first academic institution in the United States to use SCD for this type
of measurement and tracking.

"We are using Scopus Custom Data to link the University of Miami's unique
faculty identifier with the Scopus author ID to better track faculty
scholarly activity regardless of the institutional affiliation at the time of
publication, " said Jared Abramson, Director, Research Reporting at the
University of Miami. "Insight into the expertise of each of our faculty
members allows us to promote collaboration, and to build interdisciplinary
teams for institutional research projects."

The use of SCD for this type of measurement is increasingly becoming the
standard among different institutions. As research continues to become more
interdisciplinary and cross-functional, the need for a singular, more
accurate and comprehensive research tool, such as Scopus becomes a necessity
for academic institutions to remain competitive.

"We are obviously very pleased by how the University of Miami has
leveraged Scopus Custom Data through this collaboration" commented Niels
Weertman, Director Scopus, Performance & Planning at Elsevier in the Academic
& Government Products Group. "And, we see it as a significant step forward in
the advancement of research methods and international collaboration."

About Scopus

Covering the world's research literature, Scopus is the largest abstract 
and citation database of peer-reviewed literature and quality Web sources 
with smart tools to track analyze and visualize research. Scopus was designed 
and developed with over 500 users and librarians internationally. Its unique
database contains abstracts and references from nearly 18,000 titles from
more than 5,000 international publishers, ensuring broad interdisciplinary
coverage. In addition, Scopus not only offers users citation information
about the articles covered, but also directly integrates Web and patent
searches. Direct links to full-text articles, library resources and other
applications like reference management software, make Scopus quicker, easier
and more comprehensive to use than any other literature research tool. For
more information about Scopus please visit http://www.info.scopus.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (http://www.thelancet.com) and Cell
(http://www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com),
Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and
Nursing Consult (http://www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier 
(http://www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact: 
    Marwa Salem
    Phone: +31-20-485-2674
    E-mail: m.salem@elsevier.com